Welcome

ACIP Meeting for Hepislav-B

In February of 2018 the Advisory Committee on Immunization Practices (ACIP) met to approve the Hepislav-B vaccine. This vaccine produced 14 Myocardial Infarctions (Heart attacks) in the group receiving Hepislav B vaccination versus two in the control group (other Hep B vaccine). Despite legitimate questions from doctors, the vaccine was unanimously approved for use.

You can watch the full meeting here:

Sign Up for Email Action Alerts

Email Address *

First Name *

Last Name *

* indicates required


Other Useful Websites:

Hope from Holly

Vaccine Papers

National Vaccine Information Center

Informed Consent Action Network

Vaccine Injury and Compensation Program

DISCLAIMER:

All information, data and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advise. The decision to vaccinate and how you implement that decision is yours and yours alone. You are encouraged to consult with your medical professional and legal adviser.